SBFM - Sunshine Biopharma Inc (Healthcare: Drug Manufacturers - Specialty & Generic) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-01-06)
Last
 2.97		 Change
 ⇓ -0.49   (-14.16%)		 Volume
  374,419
Open
 3.46		 High
 3.46		 Low
 2.95
8EMA (Daily)
 3.07		 40EMA (Daily)
 2.89		 50EMA (Daily)
 2.85		 STO (Daily)
 63.711		 MACD Hist (Daily)
 0.041
8EMA (Weekly)
 2.992		 40EMA (Weekly)
 2.14		 50EMA (Weekly)
 1.94		 STO (Weekly)
 59.510		 MACD Hist (Weekly)
 -0.067
Company Profile
Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com